AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Clal Biotechnology Industries

5 stories about Clal Biotechnology Industries
עפר גונן מנכ"ל כלל ביוטכנולוגיה

CBI plans to issue new SPAC to merge with Israeli life science company

18.03.21|Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
הדמיה חיסון תרופה קורונה covid 19

Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials

19.08.20|Sophie Shulman
Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4
בדיקת דם 1

Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devices

26.07.20|CTech
Israeli startup develops machine vision-based technology for blood test analysis and infectious disease diagnosis
חדר מיון בית חולים שיבא תל השומר

Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight

05.07.18|CTech
The deal was announced in March, but intended buyer InSight backed out
לן בלווטניק בעל השליטה בכת"ב

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

04.07.18|CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company